|
US5470571A
(en)
|
1988-01-27 |
1995-11-28 |
The Wistar Institute |
Method of treating human EGF receptor-expressing gliomas using radiolabeled EGF receptor-specific MAB 425
|
|
FR2660556B1
(fr)
|
1990-04-06 |
1994-09-16 |
Rhone Poulenc Sante |
Microspheres, leur procede de preparation et leur utilisation.
|
|
IL98528A0
(en)
|
1990-06-21 |
1992-07-15 |
Merck & Co Inc |
Pharmaceutical compositions containing hybrid for killing bladder cancer cells
|
|
CA2082160C
(en)
|
1991-03-06 |
2003-05-06 |
Mary M. Bendig |
Humanised and chimeric monoclonal antibodies
|
|
US5811447A
(en)
|
1993-01-28 |
1998-09-22 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US6515009B1
(en)
|
1991-09-27 |
2003-02-04 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
CA2086874E
(en)
|
1992-08-03 |
2000-01-04 |
Renzo Mauro Canetta |
Methods for administration of taxol
|
|
US6306421B1
(en)
|
1992-09-25 |
2001-10-23 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US5981568A
(en)
|
1993-01-28 |
1999-11-09 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US6491938B2
(en)
|
1993-05-13 |
2002-12-10 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US6096331A
(en)
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US20030133955A1
(en)
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US5665382A
(en)
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of pharmaceutically active agents for in vivo delivery
|
|
US5650156A
(en)
|
1993-02-22 |
1997-07-22 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of nutriceuticals and compositions useful therefor
|
|
US20030068362A1
(en)
|
1993-02-22 |
2003-04-10 |
American Bioscience, Inc. |
Methods and formulations for the delivery of pharmacologically active agents
|
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
|
US5439686A
(en)
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US5997904A
(en)
|
1993-02-22 |
1999-12-07 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
|
US5362478A
(en)
|
1993-03-26 |
1994-11-08 |
Vivorx Pharmaceuticals, Inc. |
Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
|
|
NZ262679A
(en)
|
1993-02-22 |
1997-08-22 |
Vivorx Pharmaceuticals Inc |
Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
|
|
US5916596A
(en)
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US5665383A
(en)
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of immunostimulating agents for in vivo delivery
|
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US6537579B1
(en)
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
|
US6528067B1
(en)
|
1993-02-22 |
2003-03-04 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
|
US5886026A
(en)
|
1993-07-19 |
1999-03-23 |
Angiotech Pharmaceuticals Inc. |
Anti-angiogenic compositions and methods of use
|
|
CA2472404A1
(en)
|
1993-07-19 |
1995-02-02 |
Angiotech Pharmaceuticals, Inc. |
Combination of stent and anti-angiogenic factor
|
|
US6441026B1
(en)
|
1993-11-08 |
2002-08-27 |
Aventis Pharma S.A. |
Antitumor compositions containing taxane derivatives
|
|
EP0739203A4
(en)
|
1994-01-14 |
2000-12-20 |
Cell Therapeutics Inc |
METHOD OF TREATING CELL PROLIFERATION CONDITIONS IN RESPONSE TO PDGF, EGF, FGF AND VEGF
|
|
US5626862A
(en)
|
1994-08-02 |
1997-05-06 |
Massachusetts Institute Of Technology |
Controlled local delivery of chemotherapeutic agents for treating solid tumors
|
|
US5662883A
(en)
|
1995-01-10 |
1997-09-02 |
Nanosystems L.L.C. |
Microprecipitation of micro-nanoparticulate pharmaceutical agents
|
|
US5534270A
(en)
|
1995-02-09 |
1996-07-09 |
Nanosystems Llc |
Method of preparing stable drug nanoparticles
|
|
US5510118A
(en)
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
|
US5609629A
(en)
|
1995-06-07 |
1997-03-11 |
Med Institute, Inc. |
Coated implantable medical device
|
|
US6565842B1
(en)
|
1995-06-07 |
2003-05-20 |
American Bioscience, Inc. |
Crosslinkable polypeptide compositions
|
|
AU716005B2
(en)
|
1995-06-07 |
2000-02-17 |
Cook Medical Technologies Llc |
Implantable medical device
|
|
US5744460A
(en)
|
1996-03-07 |
1998-04-28 |
Novartis Corporation |
Combination for treatment of proliferative diseases
|
|
US6441025B2
(en)
|
1996-03-12 |
2002-08-27 |
Pg-Txl Company, L.P. |
Water soluble paclitaxel derivatives
|
|
CN1304058C
(zh)
|
1996-03-12 |
2007-03-14 |
Pg－Txl有限公司 |
水溶性紫杉醇产品
|
|
PT956034E
(pt)
|
1996-07-30 |
2002-12-31 |
Novartis Ag |
Composicoes farmaceuticas para o tratamento da rejeicao de transplantes estados inflamatorios ou auto-imunes compreendendo ciclosporina a e 40-o-(2-hidroxietil)-rapamicina
|
|
US8137684B2
(en)
|
1996-10-01 |
2012-03-20 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US6495579B1
(en)
|
1996-12-02 |
2002-12-17 |
Angiotech Pharmaceuticals, Inc. |
Method for treating multiple sclerosis
|
|
US6143276A
(en)
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
|
US6884879B1
(en)
|
1997-04-07 |
2005-04-26 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
KR100816621B1
(ko)
|
1997-04-07 |
2008-03-24 |
제넨테크, 인크. |
항-ｖｅｇｆ 항체
|
|
PT1023050E
(pt)
|
1997-06-27 |
2013-12-04 |
Abraxis Bioscience Llc |
Novas formulações de agentes farmacológicos, métodos para a sua preparação e métodos para a sua utilização
|
|
US8853260B2
(en)
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20030199425A1
(en)
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
|
CA2765222C
(en)
*
|
1997-06-27 |
2017-05-09 |
Abraxis Bioscience, Llc |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US6258084B1
(en)
|
1997-09-11 |
2001-07-10 |
Vnus Medical Technologies, Inc. |
Method for applying energy to biological tissue including the use of tumescent tissue compression
|
|
RS49779B
(sr)
|
1998-01-12 |
2008-06-05 |
Glaxo Group Limited, |
Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
|
|
WO1999053935A1
(en)
|
1998-04-16 |
1999-10-28 |
Ida Development A/S |
Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga
|
|
CA2362338A1
(en)
|
1998-07-30 |
2000-02-10 |
Human Rt. |
Pharmaceutically acceptable composition comprising an aqueous solution of paclitaxel and albumin
|
|
US6682758B1
(en)
|
1998-12-22 |
2004-01-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Water-insoluble drug delivery system
|
|
US6537585B1
(en)
|
1999-03-26 |
2003-03-25 |
Guilford Pharmaceuticals, Inc. |
Methods and compositions for treating solid tumors
|
|
EP1171117A4
(en)
|
1999-04-22 |
2002-08-07 |
American Bioscience Inc |
LONG-TERM ADMINISTRATION OF PHARMACOLOGICALLY ACTIVE AGENTS
|
|
HK1045646A1
(zh)
|
1999-05-21 |
2002-12-06 |
Abraxis Bioscience, Llc |
蛋白質穩定化的藥理學活性劑，其製備方法及其使用方法
|
|
KR20070058028A
(ko)
|
1999-05-24 |
2007-06-07 |
소너스파머슈티칼즈인코포레이티드 |
난용성 약물용 에멀젼 부형제
|
|
JP2003527337A
(ja)
|
1999-11-12 |
2003-09-16 |
エントレメッド インコーポレイテッド |
抗血管新生スケジュールに基づく治療薬の投与方法
|
|
US7740841B1
(en)
|
2000-01-28 |
2010-06-22 |
Sunnybrook Health Science Center |
Therapeutic method for reducing angiogenesis
|
|
AU2001253334A1
(en)
|
2000-04-10 |
2001-10-23 |
Teva Pharmaceutical Industries Ltd. |
Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
|
|
ITMI20001107A1
(it)
|
2000-05-18 |
2001-11-18 |
Acs Dobfar Spa |
Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel
|
|
AU2001273071B2
(en)
|
2000-06-30 |
2005-09-08 |
Glaxo Group Limited |
Quinazoline ditosylate salt compounds
|
|
ATE526019T1
(de)
|
2000-07-28 |
2011-10-15 |
Sloan Kettering Inst Cancer |
Verfahren zur behandlung von zellproliferationen störungen und virusinfektionen
|
|
CZ2003837A3
(cs)
|
2000-09-22 |
2004-12-15 |
Bristol-Myers Squibb Company |
Způsob pro snížení toxicity při kombinovaných chemoterapiích
|
|
DE60203260T2
(de)
|
2001-01-16 |
2006-02-02 |
Glaxo Group Ltd., Greenford |
Pharmazeutische kombination, die ein 4-chinazolinamin und paclitaxel, carboplatin oder vinorelbin enthält, zur behandlung von krebs
|
|
US6548531B2
(en)
|
2001-02-09 |
2003-04-15 |
Hoffmann-La Roche Inc. |
Method for cancer therapy
|
|
GB0103668D0
(en)
|
2001-02-15 |
2001-03-28 |
Biointeractions Ltd |
Methods and clinical devices for the inhibition or prevention of mammalian cell growth
|
|
MXPA03007989A
(es)
|
2001-03-06 |
2003-12-04 |
Bristol Myers Squibb Co |
Metodo y forma de dosificacion para tratamiento de tumores por administracion de tegafur, uracil, acido folinico, paclitaxel y carboplatin.
|
|
WO2002069949A2
(en)
|
2001-03-06 |
2002-09-12 |
Prendergast Patrick T |
Combination therapy for reduction of toxycity of chemotherapeutic agents
|
|
US6752922B2
(en)
|
2001-04-06 |
2004-06-22 |
Fluidigm Corporation |
Microfluidic chromatography
|
|
US7638161B2
(en)
|
2001-07-20 |
2009-12-29 |
Applied Materials, Inc. |
Method and apparatus for controlling dopant concentration during BPSG film deposition to reduce nitride consumption
|
|
US6872715B2
(en)
|
2001-08-06 |
2005-03-29 |
Kosan Biosciences, Inc. |
Benzoquinone ansamycins
|
|
US7056338B2
(en)
|
2003-03-28 |
2006-06-06 |
Conor Medsystems, Inc. |
Therapeutic agent delivery device with controlled therapeutic agent release rates
|
|
US20040033271A1
(en)
|
2001-12-03 |
2004-02-19 |
Seth Lederman |
Methods for contemporaneous administration of levamisole and 5-fluorouracil
|
|
US20040143004A1
(en)
|
2002-02-26 |
2004-07-22 |
Joseph Fargnoli |
Metronomic dosing of taxanes
|
|
ITMI20020681A1
(it)
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina
|
|
ITMI20020680A1
(it)
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
Composizione antitumorale migliorata a base di paclitaxel e metodo per il suo ottenimento
|
|
US20040126400A1
(en)
|
2002-05-03 |
2004-07-01 |
Iversen Patrick L. |
Delivery of therapeutic compounds via microparticles or microbubbles
|
|
US7794743B2
(en)
|
2002-06-21 |
2010-09-14 |
Advanced Cardiovascular Systems, Inc. |
Polycationic peptide coatings and methods of making the same
|
|
AU2003251955A1
(en)
|
2002-07-16 |
2004-02-02 |
Sonus Pharmaceuticals, Inc. |
Platinum compound
|
|
AU2003250483A1
(en)
|
2002-08-19 |
2004-03-11 |
Pfizer Products Inc. |
Combination therapy for hyperproliferative diseases
|
|
US20040047835A1
(en)
|
2002-09-06 |
2004-03-11 |
Cell Therapeutics, Inc. |
Combinatorial drug therapy using polymer drug conjugates
|
|
US20050095267A1
(en)
|
2002-12-04 |
2005-05-05 |
Todd Campbell |
Nanoparticle-based controlled release polymer coatings for medical implants
|
|
CA2509365C
(en)
|
2002-12-09 |
2012-08-07 |
American Bioscience, Inc. |
Compositions and methods of delivery of pharmacological agents
|
|
KR20120068035A
(ko)
|
2002-12-09 |
2012-06-26 |
아브락시스 바이오사이언스, 엘엘씨 |
약리학적 물질의 조성물 및 그 전달방법
|
|
WO2004062604A2
(en)
|
2003-01-10 |
2004-07-29 |
Threshold Pharmaceuticals, Inc. |
Treatment of cancer with 2-deoxyglucose
|
|
RU2005133199A
(ru)
|
2003-03-28 |
2006-02-10 |
Козан Байосайенсиз, Инк. (Us) |
Устройства, способы и композиции для предупреждения рестеноза
|
|
EP1643971A2
(en)
|
2003-05-22 |
2006-04-12 |
Neopharm, Inc. |
Liposomal formulations comprising a combination of two or more active agents
|
|
UA101945C2
(uk)
|
2003-05-30 |
2013-05-27 |
Дженентек, Инк. |
Лікування злоякісного новоутворення за допомогою бевацизумабу
|
|
US20050026893A1
(en)
|
2003-05-30 |
2005-02-03 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with immunosuppressants
|
|
AR046510A1
(es)
|
2003-07-25 |
2005-12-14 |
Regeneron Pharma |
Composicion de un antagonista de vegf y un agente anti-proliferativo
|
|
US20080085902A1
(en)
|
2003-09-23 |
2008-04-10 |
Guido Bold |
Combination Of A Vegf Receptor Inhibitor Or With A Chemotherapeutic Agent
|
|
WO2005039533A1
(en)
|
2003-10-15 |
2005-05-06 |
Medigene Ag |
Method of administering cationic liposomes comprising an active drug
|
|
WO2005042539A1
(en)
|
2003-10-29 |
2005-05-12 |
Sonus Pharmaceuticals, Inc. |
Tocopherol-modified therapeutic drug compounds
|
|
US20080045559A1
(en)
|
2003-10-29 |
2008-02-21 |
Sonus Pharmaceuticals, Inc. |
Tocopherol-modified therapeutic drug compounds
|
|
US20050203174A1
(en)
|
2004-03-09 |
2005-09-15 |
Kosan Biosciences, Inc. |
Combination therapies using leptomycin B
|
|
CA2560059A1
(en)
|
2004-03-15 |
2005-09-29 |
Sonus Pharmaceuticals, Inc. |
Platinum carboxylate anticancer compounds
|
|
WO2006001911A2
(en)
|
2004-05-06 |
2006-01-05 |
Genentech, Inc. |
Crystal structure of the hepatocyte growth factor beta chain and methods of use
|
|
AU2006249235B2
(en)
|
2004-05-14 |
2010-11-11 |
Abraxis Bioscience, Llc |
Sparc and methods of use thereof
|
|
US8420603B2
(en)
|
2004-05-14 |
2013-04-16 |
Abraxis Bioscience, Llc |
SPARC and methods of use thereof
|
|
EP2784082B1
(en)
|
2004-05-14 |
2017-12-27 |
Abraxis BioScience, LLC |
Disease site-delivering pharmaceutical compositions comprising paclitaxel.
|
|
NZ579482A
(en)
|
2004-06-01 |
2011-02-25 |
Genentech Inc |
Antibody drug conjugates and methods
|
|
AU2005249566B2
(en)
|
2004-06-04 |
2010-11-11 |
Genentech, Inc. |
Method for treating multiple sclerosis
|
|
GT200500155A
(es)
|
2004-06-16 |
2006-05-15 |
|
Terapia del càncer resistente al platino
|
|
US8772269B2
(en)
|
2004-09-13 |
2014-07-08 |
Eisai R&D Management Co., Ltd. |
Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
|
|
US8735394B2
(en)
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
KR20070114753A
(ko)
|
2005-02-18 |
2007-12-04 |
아브락시스 바이오사이언스 인크. |
치료제의 조합 및 투여 방식, 및 조합 요법
|
|
AU2006237613A1
(en)
|
2005-02-18 |
2006-10-26 |
Abraxis Bioscience, Inc. |
Q3 SPARC deletion mutant and uses thereof
|
|
US20070166388A1
(en)
|
2005-02-18 |
2007-07-19 |
Desai Neil P |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
JP2008531591A
(ja)
|
2005-02-24 |
2008-08-14 |
エラン・ファルマ・インターナショナル・リミテッド |
ドセタキセルおよびそれらの類似体のナノ粒子製剤
|
|
CA2599301A1
(en)
|
2005-02-28 |
2006-08-31 |
Eisai R & D Management Co., Ltd. |
Novel use of sulfonamide compound in combination with angiogenesis inhibitor
|
|
EP1896007B1
(en)
|
2005-05-04 |
2014-03-19 |
Medigene AG |
Method of administering a cationic liposomal preparation comprising paclitexel
|
|
US20080221135A1
(en)
|
2005-05-13 |
2008-09-11 |
Bristol-Myers Squibb Company |
Combination therapy
|
|
LT3311805T
(lt)
|
2005-08-31 |
2020-04-27 |
Abraxis Bioscience, Llc |
Kompozicijos, apimančios silpnai vandenyje tirpius farmacinius agentus ir priešmikrobinius agentus
|
|
EP3527202A1
(en)
|
2005-08-31 |
2019-08-21 |
Abraxis BioScience, LLC |
Compositions and methods for preparation of poorly water soluble drugs with increased stability
|
|
ATE492651T1
(de)
|
2005-11-10 |
2011-01-15 |
Bristol Myers Squibb Pharma Co |
Moesin, caveolin 1 und yes-assoziiertes protein 1 als prädiktive marker der reaktion auf dasatinib bei brustkrebs
|
|
WO2007059116A2
(en)
|
2005-11-14 |
2007-05-24 |
Abraxis Bioscience, Inc. |
Geldanamycin derivatives and pharmaceutical compositions thereof
|
|
BRPI0709075A2
(pt)
|
2006-03-20 |
2011-10-11 |
Medigene Ag |
tratamento de cáncer de mama triplo receptor negativo
|
|
US20080280987A1
(en)
|
2006-08-31 |
2008-11-13 |
Desai Neil P |
Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
|
|
EP2056812A1
(en)
|
2006-08-31 |
2009-05-13 |
Abraxis BioScience, LLC |
Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
|
|
US20100112077A1
(en)
|
2006-11-06 |
2010-05-06 |
Abraxis Bioscience, Llc |
Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer
|
|
EP3470071A1
(en)
|
2006-12-14 |
2019-04-17 |
Abraxis BioScience, LLC |
Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
|
|
EP2131821B1
(en)
|
2007-03-07 |
2018-05-09 |
Abraxis BioScience, LLC |
Nanoparticle comprising rapamycin and albumin as anticancer agent
|
|
ES2389828T3
(es)
*
|
2007-04-13 |
2012-11-02 |
Abraxis Bioscience, Inc. |
Composiciones que comprenden polipéptidos SPARC
|
|
US20100166869A1
(en)
|
2007-05-03 |
2010-07-01 |
Desai Neil P |
Methods and compositions for treating pulmonary hypertension
|
|
JP5579057B2
(ja)
|
2007-06-01 |
2014-08-27 |
アブラクシス バイオサイエンス， エルエルシー |
再発性癌の処置のための方法および組成物
|
|
CN101815793A
(zh)
*
|
2007-06-15 |
2010-08-25 |
南佛罗里达大学 |
诊断和治疗癌症的方法
|
|
WO2009009587A2
(en)
|
2007-07-09 |
2009-01-15 |
Board Of Regents Of The University Of Nebraska |
Apoptosis-modulating protein therapy for proliferative disorders and nanoparticles containing the same
|
|
MX2010011165A
(es)
|
2008-04-10 |
2011-02-22 |
Abraxis Bioscience Llc |
Composiciones de derivados de taxano hidrofobos y sus usos.
|
|
TW200942233A
(en)
|
2008-04-10 |
2009-10-16 |
Abraxis Bioscience Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
|
CA2746129A1
(en)
|
2008-12-11 |
2010-06-17 |
Abraxis Bioscience, Llc |
Combination chemotherapy of nanoparticulate taxanes and inhibitors of pro-survival and/or inflammatory signals
|
|
WO2010096627A1
(en)
|
2009-02-20 |
2010-08-26 |
Lisanti Michael P |
Therapeutics and methods for treating neoplastic diseases comprising determining the level of caveolin-1 and/or caveolin-2 in a stromal cell sample
|
|
WO2010105172A1
(en)
|
2009-03-13 |
2010-09-16 |
Abraxis Bioscience, Llc |
Combination therapy with thiocolchicine derivatives
|
|
CA2758200A1
(en)
|
2009-04-10 |
2010-10-14 |
Abraxis Bioscience, Llc |
Nanoparticle formulations and uses thereof
|
|
PT2419732T
(pt)
|
2009-04-15 |
2019-12-24 |
Abraxis Bioscience Llc |
Composições e métodos de nanopartículas isentas de priões
|
|
EP3103452A1
(en)
|
2009-08-25 |
2016-12-14 |
Abraxis BioScience, LLC |
Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors
|
|
NZ602382A
(en)
|
2010-03-26 |
2014-11-28 |
Abraxis Bioscience Llc |
Methods of treatment of hepatocellular carcinoma
|
|
EP3141245A1
(en)
|
2010-03-29 |
2017-03-15 |
Abraxis BioScience, LLC |
Methods of treating cancer
|
|
MX2012011155A
(es)
|
2010-03-29 |
2012-12-05 |
Abraxis Bioscience Llc |
Metodos para mejorar suministros de farmacos y efectividad de agentes terapeuticos.
|
|
CA2801314A1
(en)
|
2010-06-02 |
2011-12-08 |
Abraxis Bioscience, Llc |
Methods of treating bladder cancer
|
|
MX347225B
(es)
|
2010-06-04 |
2017-04-19 |
Abraxis Bioscience Llc * |
Metodos de tratamiento contra el cancer pancreatico.
|
|
JP6031437B2
(ja)
|
2010-06-07 |
2016-11-24 |
アブラクシス バイオサイエンス， エルエルシー |
増殖性疾患を処置するための組み合わせ療法
|
|
KR101970342B1
(ko)
|
2011-04-28 |
2019-04-18 |
아브락시스 바이오사이언스, 엘엘씨 |
나노입자 조성물의 혈관내 전달 및 그의 용도
|
|
EP3560486A1
(en)
|
2011-12-14 |
2019-10-30 |
Abraxis BioScience, LLC |
Use of polymeric excipients for lyophilization or freezing of particles
|
|
US9149455B2
(en)
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
|
US20140186447A1
(en)
|
2012-12-28 |
2014-07-03 |
Abraxis Bioscience, Llc |
Nanoparticle compositions of albumin and paclitaxel
|
|
US20140199405A1
(en)
|
2013-01-11 |
2014-07-17 |
Abraxis Bioscience, Llc |
Method for treating cancer based on mutation status of k-ras
|
|
US9511046B2
(en)
|
2013-01-11 |
2016-12-06 |
Abraxis Bioscience, Llc |
Methods of treating pancreatic cancer
|
|
US20140199404A1
(en)
|
2013-01-11 |
2014-07-17 |
Abraxis Bioscience, Llc |
Method for treating cancer based on level of a nucleoside transporter
|
|
KR102148551B1
(ko)
|
2013-02-11 |
2020-08-26 |
아브락시스 바이오사이언스, 엘엘씨 |
흑색종을 치료하는 방법
|
|
EP3698784A1
(en)
|
2013-03-12 |
2020-08-26 |
Abraxis BioScience, LLC |
Methods of treating lung cancer
|
|
JP6387389B2
(ja)
|
2013-03-13 |
2018-09-05 |
アブラクシス バイオサイエンス， エルエルシー |
小児充実性腫瘍の処置の方法
|
|
RU2015143490A
(ru)
|
2013-03-14 |
2017-04-26 |
АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи |
Способы лечения рака мочевого пузыря
|